EMTC-M Share Price Performance
Recent EMTC-M News & Updates
No updates
Elbit Medical Technologies Ltd Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.0091
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Elbit Medical Technologies Ltd Competitors
About EMTC-M
- Founded
- n/a
- Employees
- 412
- CEO
- Website
Elbit Medical Technologies Ltd, an investment holding company, engages in the research, development, production, and marketing of therapeutic medical systems in the United States, Europe, and internationally. The company is developing a magnetic resonance imaging guided focused ultrasound treatment equipment to address various oncology and gynecology indications, as well as neurological disorders and tumors. It is also involved in the study and development of medical products based on stem cells originating primarily from the umbilical cord blood that are used for bone marrow transplants in the patients of leukemia or cancer of lymph nodes, non-malignant blood diseases, and metabolic genetic disorders. The company is based in Petah Tikva, Israel. Elbit Medical Technologies Ltd is a subsidiary of Exigent Management Ltd.
Israeli Market Performance
- 7 Days: -1.5%
- 3 Months: 21.2%
- 1 Year: 66.8%
- Year to Date: 28.8%
Over the last 7 days, the market has dropped 1.5%, driven by a loss of 1.9% in the Financials sector. In contrast to the last week, the market is actually up 67% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading